<SEC-DOCUMENT>0001516551-21-000015.txt : 20211006
<SEC-HEADER>0001516551-21-000015.hdr.sgml : 20211006
<ACCEPTANCE-DATETIME>20211005204342
ACCESSION NUMBER:		0001516551-21-000015
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20211005
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211006
DATE AS OF CHANGE:		20211005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Skye Bioscience, Inc.
		CENTRAL INDEX KEY:			0001516551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450692882
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55136
		FILM NUMBER:		211308523

	BUSINESS ADDRESS:	
		STREET 1:		11250 EL CAMINO REAL, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 410-0266

	MAIL ADDRESS:	
		STREET 1:		11250 EL CAMINO REAL, SUITE 100
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Bioscience, Inc.
		DATE OF NAME CHANGE:	20190325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nemus Bioscience, Inc.
		DATE OF NAME CHANGE:	20141030

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LOAD GUARD LOGISTICS, INC.
		DATE OF NAME CHANGE:	20121107
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>skye-20211005.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:84aa40ed-94b7-4bca-be22-82e069d12f70,g:873e8eb6-9cf9-468e-a882-ec33a291ce0c,d:20e89016e1b841b8a95f99ab92f5f69b--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>skye-20211005</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl80L2ZyYWc6MDg1MDQ3MmNmMWE0NDU1NDlhYjRhNjY0M2Y5MWQ5OWMvdGFibGU6NTQxMGZhMjNhMGJiNGEwNGI4ZTU4MmM0NTIwOGE2YWUvdGFibGVyYW5nZTo1NDEwZmEyM2EwYmI0YTA0YjhlNTgyYzQ1MjA4YTZhZV8wLTEtMS0xLTE5MDU1_6dbe5bc8-1fd3-4373-b569-03385859e857">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl80L2ZyYWc6MDg1MDQ3MmNmMWE0NDU1NDlhYjRhNjY0M2Y5MWQ5OWMvdGFibGU6NTQxMGZhMjNhMGJiNGEwNGI4ZTU4MmM0NTIwOGE2YWUvdGFibGVyYW5nZTo1NDEwZmEyM2EwYmI0YTA0YjhlNTgyYzQ1MjA4YTZhZV8xLTEtMS0xLTE5MDU1_4730c24a-b285-43b0-a4db-5fd6f54d9402">0001516551</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="skye-20211005.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-29</xbrli:startDate><xbrli:endDate>2021-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef763569f8e466b8f4a62b0d0622485_D20211005-20211005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-05</xbrli:startDate><xbrli:endDate>2021-10-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i20e89016e1b841b8a95f99ab92f5f69b_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8xMDUx_b2cdefa6-9aac-4b05-b109-ce87ae14ce6b">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="i6ef763569f8e466b8f4a62b0d0622485_D20211005-20211005" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8yMzA_9b35393e-d83f-4786-b39b-ebe54991b2f7">October 5, 2021</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.993%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8xMDUy_07bb63ef-6e62-46a7-8535-f0258222c1cf">SKYE BIOSCIENCE, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:28.993%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.018%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.018%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6ODFmYTA2N2FjNmQ4NDAxZjlkYWFmMDM0ZjQzMDkwMGQvdGFibGVyYW5nZTo4MWZhMDY3YWM2ZDg0MDFmOWRhYWYwMzRmNDMwOTAwZF8wLTAtMS0xLTE5MDU1_fd86798a-b091-46a7-81c4-3634127d69d3">Nevada</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6ODFmYTA2N2FjNmQ4NDAxZjlkYWFmMDM0ZjQzMDkwMGQvdGFibGVyYW5nZTo4MWZhMDY3YWM2ZDg0MDFmOWRhYWYwMzRmNDMwOTAwZF8wLTItMS0xLTE5MDU1_fdfc4c76-eab3-4c2e-b8dd-e0c408d0d7a1">000-55136</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6ODFmYTA2N2FjNmQ4NDAxZjlkYWFmMDM0ZjQzMDkwMGQvdGFibGVyYW5nZTo4MWZhMDY3YWM2ZDg0MDFmOWRhYWYwMzRmNDMwOTAwZF8wLTQtMS0xLTE5MDU1_e2bf4951-b556-491b-9562-7526fb04fd69">45-0692882</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfNA_5a6f7077-fb91-44a6-918f-feb0870798cf">11250 El Camino Real</ix:nonNumeric>,  <ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfOQ_65cf8e58-350e-4f6d-92d4-9235595a3fb7">Suite 100</ix:nonNumeric>, <ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfMTM_94735c10-6bbf-47b2-9a32-fc5f60930ba5">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfMTc_4745304f-41ec-475a-b54d-32c8cbac7b3c">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfMjA_536f45f6-209f-4e13-ae4c-900e39a41bc1">92130</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Address of principal executive offices)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NjI0ZTZhMjY2ZTQ1NDVjNDgzNGIxZmZiYmVhNGY0NDIvdGFibGVyYW5nZTo2MjRlNmEyNjZlNDU0NWM0ODM0YjFmZmJiZWE0ZjQ0Ml8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246YTYwMjM4NjJkMTZiNDFhMzg1ZTRhMTM4YjM1YmViOGNfNQ_be80b432-a9dc-40f1-a3c0-1c19be06fcab">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NjI0ZTZhMjY2ZTQ1NDVjNDgzNGIxZmZiYmVhNGY0NDIvdGFibGVyYW5nZTo2MjRlNmEyNjZlNDU0NWM0ODM0YjFmZmJiZWE0ZjQ0Ml8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246YTYwMjM4NjJkMTZiNDFhMzg1ZTRhMTM4YjM1YmViOGNfOQ_5fdee9f6-6fba-4ff7-b8e3-d6bd6dfbe5e0">410-0266</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">_________________________</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8wLTAtMS0xLTE5MDU1_251cc883-239c-4d07-abc5-117dcd4f75f0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8xLTAtMS0xLTE5MDU1_d377fdd9-9907-43a2-928f-754adbfd9bb7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8yLTAtMS0xLTE5MDU1_efb7e3e0-1ba1-411f-9947-3ba736ecaabb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8zLTAtMS0xLTE5MDU1_d92744f1-2244-4509-b53c-e913af817131">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="padding-left:288pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8xMDUz_a8daa0c2-6842-43bb-af94-1760731a9aa1">&#9744;</ix:nonNumeric></span></div><div style="padding-left:288pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i20e89016e1b841b8a95f99ab92f5f69b_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5 &#8211; Corporate Governance and Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 4, 2021, Punit Dhillon has tendered his resignation from his position as the interim  Principal Accounting Officer of Skye Bioscience, Inc. (the &#8220;Company&#8221;). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 4, 2021, the Board of Directors of the Company (the &#8220;Board&#8221;) appointed Kaitlyn Arsenault as the new Chief Financial Officer of the Company, effective immediately.  In connection with her appointment, the Company has agreed to grant Ms. Arsenault options to purchase 1,600,000 shares of the Company's common stock at an exercise price of $0.09 per share, with 10% of such options vested immediately upon grant and the remaining 90% vesting in equally in semi-annual installments over four years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has entered into an employment agreement with Ms. Arsenault, which provides for an annual base salary of $300,000 per year and an annual discretionary bonus up to thirty-five percent (35%) of her base salary based in part on Ms. Arsenault&#8217;s achievement of milestones agreed to by the Board or the Compensation Committee of the Board. Ms. Arsenault will also receive the normal benefits available to other similarly situated executives and will be entitled to severance pay under the circumstances described below.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Arsenault&#8217;s employment with the Company is at-will. Except for termination of Ms. Arsenault&#8217;s employment for &#8220;Cause,&#8221; &#8220;By Death&#8221; or &#8220;By Disability&#8221; (as such terms are defined in the employment agreement), Ms. Arsenault will be entitled to a severance payment in an amount equal to six months&#8217; of her then-current base salary. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Arsenault&#8217;s new employment agreement also contains certain restrictive covenants, including confidentiality and non-solicitation clauses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summary of Ms. Arsenault&#8217;s new employment agreement does not purport to be complete and is qualified in its entirety by the full text of such agreement, a copy of which is filed hereto as Exhibit 10.1, and which is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 8 - Other Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 Other Events.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2021, the Company issued a press release announcing the appointment of Ms. Arsenault as the new Chief Financial Officer. A copy of the press release is attached hereto as Exhibit 99.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Item 8.01 of this Report shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any of the Company&#8217;s filings with the Securities and Exchange Commission under the Exchange Act or the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 9 - Financial Statements and Exhibits </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a211004_skyexhrxusxexecuti.htm">Executive Employment Agreement, dated October 4, 2021, by and between the Company and Kaitlyn Arsenault</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a211001_skyecfoannouncemen.htm">Press Release</a></span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Furnished herewith. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:0.75pt;padding-left:5.3pt"><span><br/></span></div><div style="padding-left:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.090%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i20e89016e1b841b8a95f99ab92f5f69b_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SKYE BIOSCIENCE, INC.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated:  October 5, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/&#160; Punit Dhillon</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name: Punit Dhillon</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title: Chief Executive Officer</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a211004_skyexhrxusxexecuti.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6a790b1ee2f84555b6718a6916b6e50f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">Executive Employment Agreement</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Executive Employment Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), dated October 4, 2021, is between Skye Bioscience, inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Kaitlyn Arsenault (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:28.34pt">POSITION AND RESPONSIBILITIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Position.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive is employed by the Company to render services to the Company in the position of Chief Financial Officer reporting directly to the Chief Executive Officer (CEO).  Executive shall perform the duties and responsibilities as are normally related to such position in accordance with the standards of the industry within which the Company operates and any additional duties now or hereafter assigned to Executive by the CEO.  Executive shall abide by the Company&#8217;s rules, regulations, and practices as adopted or modified from time to time in the Company&#8217;s sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">Other Activities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Except upon the prior written consent of the Board, or as disclosed on Schedule A of this Agreement, the Executive will not, during the term of this Agreement, (i)&#160;accept any other employment, or (ii)&#160;engage, directly or indirectly, in any other business activity (whether or not pursued for pecuniary advantage), that might interfere with Executive&#8217;s duties and responsibilities hereunder or create a potential conflict of interest with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">No Conflict. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Executive represents and warrants that Executive&#8217;s execution of this Agreement, employment with the Company, and the performance of Executive&#8217;s proposed duties under this Agreement shall not violate any obligations Executive may have to any other person or entity, including any obligations with respect to proprietary or confidential information of any other person or entity.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.68pt">COMPENSATION AND BENEFITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Base Salary.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  In consideration of the services to be rendered under this Agreement, the Company shall pay Executive a salary at the rate of $300,000 per year (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Base Salary shall be paid in accordance with the Company&#8217;s regularly established payroll practice.  Executive&#8217;s Base Salary will be reviewed from time to time in accordance with the established procedures of the Company for adjusting salaries for similarly situated employees and may be adjusted in the sole discretion of the Company.  The Base Salary will be reviewed from time to time in accordance with the established procedures of the Company for adjusting fees for similarly situated employees and may be increased in the sole discretion of the Board. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">Discretionary Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive will be eligible to earn an annual bonus up to thirty five percent (35%) of Executive&#8217;s Base Salary (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Discretionary Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company will, within 90 days of the end of each calendar year, determine the Discretionary Bonus, if any, payable to the Executive for that calendar year, based in part on the Executive&#8217;s achievement of milestones agreed to by the Board or the Compensation Committee of the Board.   Within 90 days of the beginning of each calendar year, the Board or the Compensation Committee of the Board shall determine the Executive&#8217;s milestones and the amount of bonus </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">potentially payable if one or more milestones are achieved for that year.  The Company may determine the amount of the Discretionary Bonus in its sole discretion and it may pay the Discretionary Bonus in cash, shares of the Company or stock options of the Company, or any combination thereof, and it may pay the Discretionary Bonus in a lump sum or installments, equal or otherwise.  Notwithstanding anything herein to the contrary, the Executive must be employed on the date(s) the Discretionary Bonus is to be paid to be eligible to receive the Discretionary Bonus, or portion thereof. The initial set of performance objectives will be reasonably agreed to by the Board or the Compensation Committee of the Board and Executive, within ninety (90) days of the Effective Date.  Subsequent performance objectives will be reasonably agreed to by the Board or the Compensation Committee of the Board and Executive within (90) days of the beginning of the calendar year to which the Discretionary Bonus relates</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Stock Options.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive will be granted the option to purchase 1,600,000 shares of Common Stock of the Company at a per share exercise price equal to the fair market value of such shares on the date of grant. The stock option agreement will provide, among other things, that, subject to Executive&#8217;s continued employment with the Company, the options shall vest 10% upfront and 90% in equal semiannual installments over four years from issuance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Benefits.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive shall be eligible to participate in the benefits made generally available by the Company to similarly situated executives, in accordance with the benefit plans established by the Company, and as may be amended from time to time in the Company&#8217;s sole discretion.  The Company shall reimburse to Executive for personal health benefits at the equivalent level, if the Executive opts out of the Company health plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">Vacation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Executive will be entitled to vacation in accordance with the Company&#8217;s vacation policy.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25.67pt">Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Company shall reimburse Executive for reasonable business expenses incurred in the performance of Executive&#8217;s duties hereunder in accordance with the Company&#8217;s expense reimbursement guidelines.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.02pt">TERMINATION AND TERMINATION RIGHTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Termination by Company Without Cause.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Company may terminate Executive&#8217;s employment with the Company at any time, without any advance notice, for any reason or no reason at all, notwithstanding anything to the contrary contained in or arising from this Agreement or any statements, policies or practices of the Company relating to the employment, discipline or termination of its employees.  Upon and after such termination, all obligations of the Company under this Agreement shall cease, except as otherwise provided herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">Severance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Except in situations where the employment of Executive is terminated For Cause, By Death or By Disability (as defined in Section&#160;IV below), in the event that (i)&#160;the Company terminates Executive&#8217;s employment, then Executive will be entitled to payment by the Company of an amount equal to six months of Executive&#8217;s then-current Base Salary, less applicable statutory deductions and withholdings (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), to be paid as salary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">continuation (and not as a lump sum) over the applicable period and in accordance with the Company&#8217;s standard payroll practices.  Executive&#8217;s eligibility for the foregoing Severance is conditioned on Executive having first signed a release agreement in the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Additionally, Executive shall not be entitled to any Severance if Executive&#8217;s employment is terminated by Executive.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">OTHER TERMINATIONS BY COMPANY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Termination for Cause.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">For Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean&#58; (i)&#160;Executive commits a act involving dishonesty, breach of trust, or physical harm to any person&#59; (ii)&#160;Executive willfully engages in conduct that is in bad faith and materially injurious to the Company&#59; (iii)&#160;Executive commits a material breach of this Agreement, which breach is not cured within 30 days after written notice to Executive from the Company&#59; (iv)&#160;Executive willfully refuses to implement or follow a lawful policy or directive of the Company, which breach is not cured within 30 days after written notice to Executive from the Company&#59; or (v)&#160;Executive engages in misfeasance or malfeasance demonstrated by a pattern of failure to perform job duties diligently and professionally.  The Company may terminate Executive&#8217;s employment For Cause at any time, without any advance notice.  The Company shall pay to Executive all compensation to which Executive is entitled up through the date of termination, subject to any other rights or remedies of the Company under law&#59; and thereafter all obligations of the Company under this Agreement shall cease. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">By Death.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive&#8217;s employment shall terminate automatically upon Executive&#8217;s death.  The Company shall pay to Executive&#8217;s beneficiaries or estate, as appropriate, any compensation then due and owing.  Thereafter all obligations of the Company under this Agreement shall cease.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">By Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  If Executive becomes eligible for the Company&#8217;s long term disability benefits or if, in the sole opinion of the Company, Executive is unable to carry out the responsibilities and functions of the position held by Executive by reason of any physical or mental impairment then the Company may terminate Executive&#8217;s employment.  The Company shall pay to Executive all compensation to which Executive is entitled up through the date of termination, and thereafter all obligations of the Company under this Agreement shall cease.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">TERMINATION BY EXECUTIVE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Termination by Executive.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive may terminate employment with the Company at any time for any reason or no reason at all, upon 60 days advance written notice.  During such notice period Executive shall continue to diligently perform all of Executive&#8217;s duties hereunder.  The Company shall have the option, in its sole discretion, to make Executive&#8217;s termination effective at any time prior to the end of such notice period. Thereafter all obligations of the Company shall cease and Company shall not provide any Severance under section III.B., above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">TERMINATION OBLIGATIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Return of Property.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive agrees that all property (including without limitation all equipment, tangible proprietary information, documents, records, notes, contracts and computer-generated materials) furnished to or created or prepared by Executive related to Executive&#8217;s employment belongs to the Company and shall be promptly returned to the Company upon termination of Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">Resignation and Cooperation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Upon termination of Executive&#8217;s employment, Executive shall be deemed to have resigned from all offices and directorships then held with the Company.  Following any termination of employment, Executive shall cooperate with the Company in the winding up of pending work on behalf of the Company and the orderly transfer of work to other employees.  Executive shall also cooperate with the Company in the defense of any action brought by any third party against the Company that relates to Executive&#8217;s employment by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.02pt">INVENTIONS AND PROPRIETARY INFORMATION&#59; PROHIBITION ON THIRD PARTY INFORMATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Proprietary Information Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive has entered into and agrees to continue to be bound by the terms of the Company&#8217;s Proprietary Information and Inventions Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Proprietary Information Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) attached hereto as Exhibit B. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">NonSolicitation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive acknowledges that because of Executive&#8217;s position in the Company, Executive will have access to material intellectual property and confidential information.  During the term of Executive&#8217;s employment and for one year thereafter, in addition to Executive&#8217;s other obligations hereunder or under the Proprietary Information Agreement, Executive shall not directly or indirectly (i) solicit, induce, recruit or encourage any person employed by, or consulting to, the Company to terminate his or her employment or engagement, or (ii) divert or attempt to divert from the Company any business with any customer, client, member, business partner or supplier. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">NonDisclosure of Third Party Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive represents, warrants and covenants that Executive shall not disclose to the Company, or use, or induce the Company to use, any proprietary information or trade secrets of others at any time, including but not limited to any proprietary information or trade secrets of any former employer, if any&#59; and Executive acknowledges and agrees that any violation of this provision shall be grounds for Executive&#8217;s immediate termination and could subject Executive to substantial civil liabilities and criminal penalties.  Executive further specifically and expressly acknowledges that no officer or other employee or representative of the Company has requested or instructed Executive to disclose or use any such third party proprietary information or trade secrets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:10.36pt">LIABILITY COVERAGE</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company agrees to maintain commercially reasonable Director&#8217;s and Officer&#8217;s Insurance covering the customary potential liabilities of the Executive as an officer of the Company.   </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">ARBITRATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company and Executive agree that any dispute or controversy arising out of, relating to, or in connection with this Agreement, or the interpretation, validity, construction, performance, breach, or termination thereof shall be settled by arbitration to be held in San Diego, California, in accordance with the Judicial Arbitration and Mediation Service&#47;Endispute, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">JAMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) rules for employment disputes then in effect (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator&#8217;s decision in any court having jurisdiction. The arbitrator shall award the prevailing party all reasonable costs and attorneys&#8217; fees incurred during any such proceeding. The arbitrator shall apply California law to the merits of any dispute or claim. Executive hereby expressly consents to the personal jurisdiction of the state and federal courts located in San Diego, California for any action or proceeding arising from or relating to this Agreement or relating to any arbitration in which the parties are participants. The parties may apply to any court of competent jurisdiction for a temporary restraining order, preliminary injunction, or other interim or conservatory relief, as necessary, without breach of this arbitration agreement and without abridgment of the powers of the arbitrator. EXECUTIVE HAS READ AND UNDERSTANDS THIS SECTION, WHICH DISCUSSES ARBITRATION. EXECUTIVE UNDERSTANDS THAT BY SIGNING THIS AGREEMENT, EXECUTIVE AGREES TO SUBMIT ANY FUTURE CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH EXECUTIVE&#8217;S EMPLOYMENT OR TERMINATION THEREOF, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE OR BREACH OF THIS AGREEMENT, TO BINDING ARBITRATION, AND THAT THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER OF EXECUTIVE&#8217;S RIGHT TO A JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS OF THE EMPLOYER&#47;EXECUTIVE RELATIONSHIP, INCLUDING BUT NOT LIMITED TO, DISCRIMINATION CLAIMS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">AMENDMENTS&#59; WAIVERS&#59; REMEDIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may not be amended or waived except by a writing signed by Executive and by a duly authorized representative of the Company other than Executive.  Failure to exercise any right under this Agreement shall not constitute a waiver of such right.  Any waiver of any breach of this Agreement shall not operate as a waiver of any subsequent breaches.  All rights or remedies specified for a party herein shall be cumulative and in addition to all other rights and remedies of the party hereunder or under applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.68pt">ASSIGNMENT&#59; BINDING EFFECT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.34pt">Assignment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The performance of Executive is personal hereunder, and Executive agrees that Executive shall have no right to assign and shall not assign or purport to assign any rights or obligations under this Agreement.  This Agreement may be assigned or transferred by the Company&#59; and nothing in this Agreement shall prevent the consolidation, merger or sale of the Company or a sale of any or all or substantially all of its assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:25pt">Binding Effect.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Subject to the foregoing restriction on assignment by Executive, this Agreement shall inure to the benefit of and be binding upon each of the parties&#59; the affiliates, officers, directors, agents, successors and assigns of the Company&#59; and the heirs, devisees, spouses, legal representatives and successors of Executive.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.02pt">NOTICES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All notices or other communications required or permitted hereunder shall be made in writing and shall be deemed to have been duly given if delivered&#58;  (a) by hand&#59; (b) by email, (c) by a nationally recognized overnight courier service&#59; or (d) by United States first class registered or certified mail, return receipt requested, to the principal address of the other party, as set forth below.  The date of notice shall be deemed to be the earlier of (i) actual receipt of notice by any permitted means, or (ii) five business days following dispatch by overnight delivery service or the United States Mail.  Executive shall be obligated to notify the Company in writing of any change in Executive&#8217;s address.  Notice of change of address or email shall be effective only when done in accordance with this Section XII.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company&#8217;s Notice Address&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11250 El Camino Real, Suite 100<br>San Diego, CA<br>92130, USA</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive&#8217;s Notice Address and Email&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Kaitlyn Arsenault<br>2021 Fillmore Street, Suite 1026<br>San Francisco, CA<br>94115, USA</font><font style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">kait&#64;karsenaultconsulting.com</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:10.36pt">SEVERABILITY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any provision of this Agreement shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to the fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect.  In the event that the time period or scope of any provision is declared by a court or arbitrator of competent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall reduce the time period or scope to the maximum time period or scope permitted by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XIV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.02pt">TAXES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All amounts paid under this Agreement shall be paid less all applicable state and federal tax withholdings (if any) and any other withholdings required by any applicable jurisdiction or authorized by Executive.  Notwithstanding any other provision of this Agreement whatsoever, the Company, in its sole discretion, shall have the right to provide for the application and effects of Section 409A of the Code (relating to deferred compensation arrangements) and any related administrative guidance issued by the Internal Revenue Service.  The Company shall have the authority to delay the payment of any amounts under this Agreement to the extent it deems necessary or appropriate to comply with Section 409A(a)(2)(B)(i) of the Code&#59; in such event, the payment(s) at issue may not be made before the date which is six months after the date of Executive&#8217;s separation from service, or, if earlier, the date of death.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">GOVERNING LAW</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be governed by and construed in accordance with the laws of the State of California.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XVI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.02pt">INTERPRETATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party.  Sections and section headings contained in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation of this Agreement.  Whenever the context requires, references to the singular shall include the plural and the plural the singular. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XVII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:6.36pt">OBLIGATIONS SURVIVE TERMINATION OF EMPLOYMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive agrees that any and all of Executive&#8217;s obligations under this agreement, including but not limited to the Proprietary Information Agreement, shall survive the termination of employment and the termination of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XVIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:1.7pt">COUNTERPARTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of which together shall constitute one and the same instrument. </font></div><div style="margin-bottom:12pt;padding-left:40.5pt;text-align:justify;text-indent:-40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XIX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.52pt">AUTHORITY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each party represents and warrants that such party has the right, power and authority to enter into and execute this Agreement and to perform and discharge all of the obligations </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">hereunder&#59; and that this Agreement constitutes the valid and legally binding agreement and obligation of such party and is enforceable in accordance with its terms.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15.68pt">ENTIRE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement is intended to be the final, complete, and exclusive statement of the terms of Executive&#8217;s employment by the Company and may not be contradicted by evidence of any prior or contemporaneous statements or agreements, except for agreements specifically referenced herein (including the Executive Proprietary Information and Inventions Agreement).  To the extent that the practices, policies or procedures of the Company, now or in the future, apply to Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control.  Any subsequent change in Executive&#8217;s duties, position, or compensation will not affect the validity or scope of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">XXI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.02pt">EXECUTIVE ACKNOWLEDGEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EXECUTIVE ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL CONCERNING THIS AGREEMENT, THAT EXECUTIVE HAS READ AND UNDERSTANDS THE AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE&#8217;S OWN JUDGMENT AND NOT ON ANY REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Remainder of Page Intentionally Left Blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><div id="i6a790b1ee2f84555b6718a6916b6e50f_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In Witness Whereof, the parties have duly executed this Agreement as of the date first written above. </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.269%"><tr><td style="width:1.0%"></td><td style="width:49.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Skye Bioscience, Inc.</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signature</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Punit Dhillon &#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Chief Executive Officer&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Kaitlyn Arsenault</font></div><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signature</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date</font></div></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6a790b1ee2f84555b6718a6916b6e50f_7"></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Form of Separation and Release Agreement</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Separation and Release Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is entered into by and between Skye  Bioscience, inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Kaitlyn Arsenault (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), with respect to the following facts&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A.&#160;&#160;&#160;&#160;On _________, Employee and the Company entered into that certain Executive Employment Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;B.&#160;&#160;&#160;&#160;On _________, Employee&#8217;s employment with the Company was terminated and according to the terms and conditions of the Executive Employment Agreement, Employee is entitled to certain severance payments so long as Employee executes this Agreement.  By execution hereof, Employee understands and agrees that this Agreement is a compromise of doubtful and disputed claims, if any, which remain untested&#59; that there has not been a trial or adjudication of any issue of law or fact herein&#59; that the terms and conditions of this Agreement are in no way to be construed as an admission of liability on the part of Releasees (as defined below) and that Releasees deny liability and intend merely to avoid future litigation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In consideration of the aforementioned recitals and the mutual covenants and conditions set forth below and in full settlement of any and all claims arising out of the Employee&#8217;s employment or the termination of that employment, the Employee and Company hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Separation Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of Employee signing this Agreement, and the covenants and releases given herein, the Company agrees to pay Employee, upon this Agreement becoming effective, the gross sum of $____________, less federal and state withholdings (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Employee acknowledges that Employee would not be entitled to receive the Severance Pay absent this Agreement and the Executive Employment Agreement.  The Company will pay the Severance Pay to Employee as salary continuation pursuant to the terms of Section III.B. of the Executive Employment Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">General Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee, individually and on behalf of Employee&#8217;s heirs, assigns, executors, successors and each of them, hereby unconditionally, irrevocably and absolutely releases and discharges the Company, each of its subsidiaries and affiliates and each of their respective directors, officers, employees, agents, successors and assigns, and any related corporations and&#47;or entities (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) from any and all losses, liabilities, claims, demands, causes of action or suits of any type, known or unknown, including but not limited to claims related directly or indirectly to Employee's employment with Releasees, and the termination of Employee's employment with Releasees, including claims for age discrimination in violation of the Age Discrimination and Employment Act and&#47;or California Fair Employment and Housing Act, as well as all claims for wrongful termination, constructive wrongful termination, employment discrimination, </font></div><div style="height:46pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#8211; 1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">harassment, retaliation, defamation, fraud, misrepresentation, infliction of emotional distress, violation of privacy rights, and any other claims under any state or federal law.  This release also includes any claim for any and all other contractual severance, bonus, commission, other compensation or any other benefits pursuant to any other agreement, policy, and&#47;or procedure of the Company.  Employee further represents that Employee has not and will not institute, prosecute or maintain on Employee&#8217;s own behalf, before any administrative agency, court or tribunal, any demand or claim of any type related to the matters released herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Employee expressly waives all of the benefits and rights granted to Employee pursuant to California Civil Code section 1542, and any other applicable state or federal law.  Section 1542 reads as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OF OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee certifies that Employee has read all of this Agreement, including the release provisions contained herein and the quoted Civil Code section, and that Employee fully understands all of the same.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee hereby agrees that, except as required by law or court order, Employee will not describe or discuss the Company&#8217;s or any of its subsidiaries&#8217; business dealings and&#47;or confidential information with any third party, and will not describe or discuss this Agreement with any third party other than Employee&#8217;s tax or legal advisors.  Employee further agrees Employee will comply with any continuing obligations under any employment agreement and&#47;or proprietary information agreement, including but not limited to protection of the Company&#8217;s or its subsidiaries&#8217; trade secrets and nonsolicitation obligations.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Time for Consideration of This Agreement&#47;Revocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee acknowledges that Employee is hereby given 21 days from receipt of this Agreement to consider signing this Agreement, that Employee is advised to consult with an attorney before signing this Agreement, and that Employee has the right to revoke this Agreement for a period of seven days after it is executed by Employee.  In the event that Employee chooses not to sign this Agreement, or chooses to revoke this Agreement once signed, Employee will not receive the Separation Pay or any other consideration Employee would not be entitled to in the absence of this Agreement.  This Agreement shall become effective eight days after it has been signed by Employee.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">Employee acknowledges that Employee has been given the opportunity to consult with Employee&#8217;s own legal counsel with respect to the matters referenced in this Agreement, and that Employee has obtained and considered the advice of such </font></div><div style="height:46pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#8211; 2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">legal counsel as they deem necessary or appropriate, such that they have voluntarily and freely entered into this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">This Agreement contains the entire agreement between Employee and the Company and there have been no promises, inducements or agreements not expressed in this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">The provisions of this Agreement are contractual, not merely recitals, and shall be considered severable, such that if any provision or part thereof shall at any time be held invalid under any law or ruling, any and all such other provision(s) or part(s) thereof shall remain in full force and effect and continue to be enforceable.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">This Agreement may be pled as a full and complete defense and may be used as the basis for an injunction against any action, suit, or proceeding that may be prosecuted, instituted, or attempted by Employee in breach thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.68pt">This Agreement shall be interpreted, construed, governed and enforced in accordance with the laws of the State of California.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.01pt">This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legal representatives, successors and assigns.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">In any action to enforce this Agreement, the prevailing party shall be entitled to recover all reasonable attorneys&#8217; fees and costs it expended in the action.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Nothing in this Agreement shall be construed as an admission or any liability or any wrongdoing by any party to this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">This Agreement shall not be construed against any party on the grounds that such party drafted the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.67pt">Each of the Company&#8217;s subsidiaries and affilites shall be deemed to be a third party beneficiary of this Agreement.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Remainder of Page Intentionally Left Blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#93;</font></div><div style="height:46pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#8211; 3</font></div><div><font><br></font></div></div></div><div id="i6a790b1ee2f84555b6718a6916b6e50f_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the last date written below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.269%"><tr><td style="width:1.0%"></td><td style="width:49.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Skye Bioscience, Inc.</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signature</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Kaitlyn Arsenault</font></div><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.7pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signature</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:15.35pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date</font></div></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SCHEDULE A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Other Activities</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A &#8211; 5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>a211001_skyecfoannouncemen.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i15e3e9c044524339bb9fa6c0d4022313_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SAN DIEGO, CA, October 5, 2021 -- Skye Bioscience, Inc. (OTCQB&#58; SKYE) (&#8220;Skye&#8221;), a biopharmaceutical company developing proprietary cannabinoid-derived molecules to treat diseases with significant unmet need, has appointed Kaitlyn Arsenault, CPA, as Chief Financial Officer. Ms. Arsenault brings over 14 years of experience in accounting, auditing, financial reporting, mergers and acquisitions, as well as business operations in the life science and technology sectors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#34;On behalf of the board and management of Skye, I am pleased to welcome Kait to our executive leadership team at this pivotal point in our growth,&#34; said Punit Dhillon, CEO. &#34;Her extensive background working with publicly traded companies in the areas of financial reporting, technical accounting and the implementation of financial controls will play an important role for Skye as we advance our clinical development programs and achieve future growth objectives.&#34;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;I am honored to step into the CFO role at this important time for Skye,&#8221; said Ms. Arsenault. &#8220;I look forward to working with Punit and the Skye team to build on the company&#8217;s momentum and strong business fundamentals while advancing its strategic and financial priorities and its commitments to all stakeholders.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Prior to her appointment as CFO of Skye, she served as an independent consultant for emerging public and private companies, including Skye for the past six years, providing expertise and addressing complex issues related to SEC reporting, technical accounting, stock-based compensation, and revenue recognition, among other subjects. She also served as Assurance Manager in Friedman LLP's SEC practice, gaining public and private audit engagement experience across multiple industries.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ms. Arsenault received her Bachelor of Science degree in accounting from Ramapo College of New Jersey and is a Certified Public Accountant. </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Skye Bioscience</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Skye Bioscience Inc. is a biopharmaceutical company unlocking the pharmaceutical potential of cannabinoids through the development of its proprietary cannabinoid-derived molecules to treat diseases with significant unmet needs. The company&#8217;s lead program, THCVHS, is focused on treating glaucoma, the world&#8217;s leading cause of irreversible blindness. For more information, please visit&#58; www.skyebioscience.com.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CONTACT</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Karam Takhar<br>VP, Corporate Development &#38; Investor Relations<br>Email&#58; ir&#64;skyebioscience.com<br>Phone&#58; (858) 410-0266</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">FORWARD LOOKING STATEMENTS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This press release contains forward-looking statements, including statements regarding our product development, business strategy, timing of clinical trials and commercialization of cannabinoid-derived therapeutics. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management&#8217;s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including &#8220;anticipated,&#8221; &#8220;plans,&#8221; &#8220;goal,&#8221; &#8220;focus,&#8221; &#8220;aims,&#8221; &#8220;intends,&#8221; &#8220;believes,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;challenge,&#8221; &#8220;predictable,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;may&#8221; or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of Skye&#8217;s most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>skye-20211005.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:84aa40ed-94b7-4bca-be22-82e069d12f70,g:873e8eb6-9cf9-468e-a882-ec33a291ce0c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:skye="http://skyebioscience.com/20211005" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://skyebioscience.com/20211005">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="skye-20211005_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="skye-20211005_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://skyebioscience.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>skye-20211005_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:84aa40ed-94b7-4bca-be22-82e069d12f70,g:873e8eb6-9cf9-468e-a882-ec33a291ce0c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_100474be-8426-4b33-91b8-23258db5ed68_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_409fd808-686d-4418-af60-7efd2cc1c272_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_36a6de0e-3569-4203-92a1-a083bb84f9c2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c5fd8d8c-0b70-485d-9216-e80058b33510_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d598b234-0718-43d4-80f5-4e86674a946d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5fd45969-a9af-415c-9e53-4980ff5c2fe3_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_36758f0a-5378-4871-b238-98b1211b3d42_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9c618657-2bff-458e-87fb-23edd492701a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4bd0fe11-b15c-4375-8ea0-00fb7e512d61_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_42471622-1f38-4ae7-a7af-73cc69641303_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bfca30ba-1d88-4c39-a505-9f90d5d81b58_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7456061c-edb5-4aad-9e80-a71ff6d34a8f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fa2cd88e-5862-442f-ba0b-3776df5d7fe2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b26abd8b-5b53-4898-b744-3fd97239e2be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a0962705-801f-46a3-899e-e7be3d8cdeeb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4d907785-84ed-4d80-9ad8-b7d742ce5782_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_53a31215-fe0b-47e0-92c9-cad65531aa28_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0fddbc37-477b-4944-b7ec-9acc10dde119_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d8d5c236-da30-41dd-8413-8782f8e04109_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0bfba5c8-1bed-4568-a55b-8355ecd5a21b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>skye-20211005_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:84aa40ed-94b7-4bca-be22-82e069d12f70,g:873e8eb6-9cf9-468e-a882-ec33a291ce0c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://skyebioscience.com/role/CoverPage" xlink:type="simple" xlink:href="skye-20211005.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://skyebioscience.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ba97bcfc-e934-477e-9c1b-7677a7416694" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_DocumentType_ba97bcfc-e934-477e-9c1b-7677a7416694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_145e36f6-f8c3-4f01-acbe-6763de6632a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_DocumentPeriodEndDate_145e36f6-f8c3-4f01-acbe-6763de6632a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b652ae3e-cbbd-4b8a-a3ea-12c3ab63636e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityRegistrantName_b652ae3e-cbbd-4b8a-a3ea-12c3ab63636e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_10c322b5-7e2e-4126-a6d1-6ca141401bd8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_10c322b5-7e2e-4126-a6d1-6ca141401bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0fd1d19c-f6ef-48a1-bf19-115966f77c87" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityFileNumber_0fd1d19c-f6ef-48a1-bf19-115966f77c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5efbf673-da94-40a0-93b9-3bf072822e4a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityTaxIdentificationNumber_5efbf673-da94-40a0-93b9-3bf072822e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b9b4d1bd-4237-49f8-9b0f-2092a63e9de9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityAddressAddressLine1_b9b4d1bd-4237-49f8-9b0f-2092a63e9de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_b12c6ffe-8af9-40d5-9292-875c01dfb600" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityAddressAddressLine2_b12c6ffe-8af9-40d5-9292-875c01dfb600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_02ca0728-4b14-4f00-b68a-8affbd52fcc2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityAddressCityOrTown_02ca0728-4b14-4f00-b68a-8affbd52fcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0ec3c15c-b4ae-4b82-a8d2-ede15fa73e8f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityAddressStateOrProvince_0ec3c15c-b4ae-4b82-a8d2-ede15fa73e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7480d67e-c1a3-4603-9582-ca9443ca9fb9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityAddressPostalZipCode_7480d67e-c1a3-4603-9582-ca9443ca9fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d339c0e8-36aa-4f1e-9292-6a706c319115" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_CityAreaCode_d339c0e8-36aa-4f1e-9292-6a706c319115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5cdffd09-113a-40e9-a7af-cae48ed705b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_LocalPhoneNumber_5cdffd09-113a-40e9-a7af-cae48ed705b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_a05fe6a6-0096-4f31-a82d-0fa0064d67e8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_WrittenCommunications_a05fe6a6-0096-4f31-a82d-0fa0064d67e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_8c3f9892-0b32-40c1-9a7e-bbe6fb969ac8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_SolicitingMaterial_8c3f9892-0b32-40c1-9a7e-bbe6fb969ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_b61a5355-021e-481c-84be-5ed7d9289d7a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_PreCommencementTenderOffer_b61a5355-021e-481c-84be-5ed7d9289d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_eed6201e-a597-4492-a746-d518c8e3bba0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_eed6201e-a597-4492-a746-d518c8e3bba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f6535031-4b4b-4f40-a60c-d4ea6fe28205" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityEmergingGrowthCompany_f6535031-4b4b-4f40-a60c-d4ea6fe28205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8c62bd8c-5df3-4eac-91ca-2378fffb5797" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_AmendmentFlag_8c62bd8c-5df3-4eac-91ca-2378fffb5797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bc93afe9-fb2f-44c6-bbf8-91556505be3d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_68475e2a-e87c-426a-91ed-76a248b947b7" xlink:to="loc_dei_EntityCentralIndexKey_bc93afe9-fb2f-44c6-bbf8-91556505be3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>skye-20211005_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="skye-20211005.xsd" xlink:type="simple"/>
    <context id="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516551</identifier>
        </entity>
        <period>
            <startDate>2021-09-29</startDate>
            <endDate>2021-09-29</endDate>
        </period>
    </context>
    <context id="i6ef763569f8e466b8f4a62b0d0622485_D20211005-20211005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516551</identifier>
        </entity>
        <period>
            <startDate>2021-10-05</startDate>
            <endDate>2021-10-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl80L2ZyYWc6MDg1MDQ3MmNmMWE0NDU1NDlhYjRhNjY0M2Y5MWQ5OWMvdGFibGU6NTQxMGZhMjNhMGJiNGEwNGI4ZTU4MmM0NTIwOGE2YWUvdGFibGVyYW5nZTo1NDEwZmEyM2EwYmI0YTA0YjhlNTgyYzQ1MjA4YTZhZV8wLTEtMS0xLTE5MDU1_6dbe5bc8-1fd3-4373-b569-03385859e857">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl80L2ZyYWc6MDg1MDQ3MmNmMWE0NDU1NDlhYjRhNjY0M2Y5MWQ5OWMvdGFibGU6NTQxMGZhMjNhMGJiNGEwNGI4ZTU4MmM0NTIwOGE2YWUvdGFibGVyYW5nZTo1NDEwZmEyM2EwYmI0YTA0YjhlNTgyYzQ1MjA4YTZhZV8xLTEtMS0xLTE5MDU1_4730c24a-b285-43b0-a4db-5fd6f54d9402">0001516551</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8xMDUx_b2cdefa6-9aac-4b05-b109-ce87ae14ce6b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i6ef763569f8e466b8f4a62b0d0622485_D20211005-20211005"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8yMzA_9b35393e-d83f-4786-b39b-ebe54991b2f7">2021-10-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8xMDUy_07bb63ef-6e62-46a7-8535-f0258222c1cf">SKYE BIOSCIENCE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6ODFmYTA2N2FjNmQ4NDAxZjlkYWFmMDM0ZjQzMDkwMGQvdGFibGVyYW5nZTo4MWZhMDY3YWM2ZDg0MDFmOWRhYWYwMzRmNDMwOTAwZF8wLTAtMS0xLTE5MDU1_fd86798a-b091-46a7-81c4-3634127d69d3">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6ODFmYTA2N2FjNmQ4NDAxZjlkYWFmMDM0ZjQzMDkwMGQvdGFibGVyYW5nZTo4MWZhMDY3YWM2ZDg0MDFmOWRhYWYwMzRmNDMwOTAwZF8wLTItMS0xLTE5MDU1_fdfc4c76-eab3-4c2e-b8dd-e0c408d0d7a1">000-55136</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6ODFmYTA2N2FjNmQ4NDAxZjlkYWFmMDM0ZjQzMDkwMGQvdGFibGVyYW5nZTo4MWZhMDY3YWM2ZDg0MDFmOWRhYWYwMzRmNDMwOTAwZF8wLTQtMS0xLTE5MDU1_e2bf4951-b556-491b-9562-7526fb04fd69">45-0692882</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfNA_5a6f7077-fb91-44a6-918f-feb0870798cf">11250 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfOQ_65cf8e58-350e-4f6d-92d4-9235595a3fb7">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfMTM_94735c10-6bbf-47b2-9a32-fc5f60930ba5">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfMTc_4745304f-41ec-475a-b54d-32c8cbac7b3c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NDRiYjNjMTQ2ZDMwNDc5ZDg0ZTZmODY2YWE0MjUzY2UvdGFibGVyYW5nZTo0NGJiM2MxNDZkMzA0NzlkODRlNmY4NjZhYTQyNTNjZV8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246ZTc0MThjMjcyYTY2NDRiNzgzYjNmMmJiOGUyNGY5MjhfMjA_536f45f6-209f-4e13-ae4c-900e39a41bc1">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NjI0ZTZhMjY2ZTQ1NDVjNDgzNGIxZmZiYmVhNGY0NDIvdGFibGVyYW5nZTo2MjRlNmEyNjZlNDU0NWM0ODM0YjFmZmJiZWE0ZjQ0Ml8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246YTYwMjM4NjJkMTZiNDFhMzg1ZTRhMTM4YjM1YmViOGNfNQ_be80b432-a9dc-40f1-a3c0-1c19be06fcab">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6NjI0ZTZhMjY2ZTQ1NDVjNDgzNGIxZmZiYmVhNGY0NDIvdGFibGVyYW5nZTo2MjRlNmEyNjZlNDU0NWM0ODM0YjFmZmJiZWE0ZjQ0Ml8wLTAtMS0xLTE5MDU1L3RleHRyZWdpb246YTYwMjM4NjJkMTZiNDFhMzg1ZTRhMTM4YjM1YmViOGNfOQ_5fdee9f6-6fba-4ff7-b8e3-d6bd6dfbe5e0">410-0266</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8wLTAtMS0xLTE5MDU1_251cc883-239c-4d07-abc5-117dcd4f75f0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8xLTAtMS0xLTE5MDU1_d377fdd9-9907-43a2-928f-754adbfd9bb7">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8yLTAtMS0xLTE5MDU1_efb7e3e0-1ba1-411f-9947-3ba736ecaabb">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGFibGU6YzI2ZDJlOWM5ZmExNGU5NzlkODkyZWIwNDI4MzgxOGQvdGFibGVyYW5nZTpjMjZkMmU5YzlmYTE0ZTk3OWQ4OTJlYjA0MjgzODE4ZF8zLTAtMS0xLTE5MDU1_d92744f1-2244-4509-b53c-e913af817131">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwZTg5MDE2ZTFiODQxYjhhOTVmOTlhYjkyZjVmNjliL3NlYzoyMGU4OTAxNmUxYjg0MWI4YTk1Zjk5YWI5MmY1ZjY5Yl8xL2ZyYWc6NmUyYTU5MzYxYjc4NDkwOTlmOTA5YjkyYTA5NjNjMTgvdGV4dHJlZ2lvbjo2ZTJhNTkzNjFiNzg0OTA5OWY5MDliOTJhMDk2M2MxOF8xMDUz_a8daa0c2-6842-43bb-af94-1760731a9aa1">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139946249467576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Oct. 05, 2021</div></th>
<th class="th"><div>Sep. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  05,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">SKYE BIOSCIENCE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">000-55136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45-0692882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11250 El Camino Real<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">410-0266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0001516551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=+AB-VA[O8'?[_L(WJ#$&UR#-XECS?.\]7Y"OL!SY$G6=A%7I-0//#)-2,C
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M"[MBKNT#<'^ME'D?V'U7N<\>_PM02P,$%     @ =*5%4Y^@&_"Q @  X@P
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( '2E15,'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ =*5%4]?:
M6Y;N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ =*5%4YE<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !TI453"Q&'A_(#  !S
M#P  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ =*5%4Y^@&_"Q @  X@P   T              ( !-0P
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !TI453EXJ[',     3 @  "P
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52P4&      D "0 ^ @  C1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="skye-20211005.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://skyebioscience.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="skye-20211005.htm">skye-20211005.htm</File>
    <File>a211001_skyecfoannouncemen.htm</File>
    <File>a211004_skyexhrxusxexecuti.htm</File>
    <File>skye-20211005.xsd</File>
    <File>skye-20211005_lab.xml</File>
    <File>skye-20211005_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "skye-20211005.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 2,
   "dts": {
    "inline": {
     "local": [
      "skye-20211005.htm"
     ]
    },
    "labelLink": {
     "local": [
      "skye-20211005_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "skye-20211005_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "skye-20211005.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 21,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "skye",
   "nsuri": "http://skyebioscience.com/20211005",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "skye-20211005.htm",
      "contextRef": "ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://skyebioscience.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "skye-20211005.htm",
      "contextRef": "ib97b77d56e2b415e865e12edd6d41d36_D20210929-20210929",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://skyebioscience.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r3": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r4": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001516551-21-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001516551-21-000015-xbrl.zip
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M2DR\0$W)6\"5*B*!OW")*@7F*BEGWWPJ6$"[.AEK8Z<R'8/ZPWYOS-T(S<=
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M7F 0KI8-FZ!4.KP\4KD3RBM>+G-0F8K4$ I._4P%\N:P7@$UQO%C=;S3]Q:
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MOFY&6)PIJD,4\Y)J)HLUWHQ2F1BC R&R57="=7 "$Z:Q!L1+N9D//H;EA0U
MIII08:$_]S(R_LV6,XJC/"7, >5H:Q5-JXI*<?5$_D6U@$M+>F[QLX5A1E7V
M#"6H!8XIMJ_4VMMFP3A/N!-O@8Y3-@ZTVY+[TJLB=JE10EKXDI2Q;^"-Z $E
MKR[,8T7?P5."U:&61LREI2MC#Z."@/,PD.A9(D<Y@37@U7PX47D];8!U$IDC
MQ6"B9\!V9@\U_,&/K>2_:)*27P2&0?E%^DM#U=HZM=&1#!.0AX*8VKE%\";>
M:_,,FT>LP_8,E/*0@;(U:F?[^.BP*A=6X,E7),+ NANHRL.0PK?U6Y86[*6-
M\9 4J66-D?(=YYU[Y?8[ET[?O70[ ]<Y[[D#*J)W?QVZ6*7?<\XN.]T/ ^?3
M^^[9>ZK]/^N[Y]UAKU]<C- $6.D/WPUN!M?NV1!O='_M#H983X_E]/ 3EMQ?
M=#["7YTA/6C8_4   :JNGR )7#V4EGIC]X(>?^6<_@8/^J ?].$&GOV^\]%U
M/G2&;K_;(<@!PA=PS^TW#MSA\)(<M<ZG[I!G<.Z>PO@W(E<V!22A64XW%JP[
M-9!#"C8N>Q_+"#3ZE+7@60HX705:H_7\_\UCY/M5IM:F@#T,#'PLRS' 0JP@
MVN"7;-I7R&MO^NEPU*33X<Z:JS@:(W@2=F"6V:8=\ 796S$M9@D#T>25VU6H
MP*[6<JA9=^&0U7H6*)M@J(WH+$*C+4]+/IM"M5(ZXZKS1EUB]<84L&+H0[<4
M1=]:352V#? 3V<ND7TUD$IBVG[8J6#_$<J^,FJ>H0Q>6J$93Q&8@\#CN)NP%
M(!/B)*W36M5"EQ?.;OU FCK[BRFTN0(%3*D[EB%N^[(M/=K 8MFK\U $8;@_
M$[[M.ZC9OW4;AXAA)./ ;DH57#DU,<?0,#^SF-1.G)58\_BQB#-\+]F29]4X
M7AG,CBBR3UY>O* I8N^.V)),M5#DB.)A6W7G19>DU>=WM>.+#FFNC6"NO(@D
MA7(R<G-'+00<, 7!&!!+;7C>'16M:C*EACWH9/^\@O1*C@#3>6M,9G_$4^7.
M+Y(2C SVR:@(G=:VS2LTK$E,C0)0IL#;<> KHT81KBY;.\ 8@VIX-W9Y7CUI
MRJ$^.[A==DB4 \WWAQ 5G!_%"_TZ@#NG0N(&:AK$N-W>F&BOLJ"X-Y1.Q?,J
M+>I.$MK<>O)8)*&.[5T;4V"C0N[;&_0-)AJO.42C 6L?<.(8H< '#L%KSV9Q
MDB'"QW+E<*AU4[+FB8#XJ0AKZP4*YZ)!5UWI^[+N.(E'RK35#950H*H.DWB&
ML9PD$.5=9&8U,G/XN",SS?+9E2F==9TE=7E8VUY/M1[6*<A+AG:; QE%8"))
ME7TP!B8(5\HB'H9M^R,(UU%SA"LU*5W!@4<9Q:HOZG.)L&QC7;^WMAA&?::L
M][E@<1R1(8R9]11XQ[:V-9#6I$.J8$"=3/VQB<9O#M&H$WEX'ZHV5AY8\= 6
M;;!*_=?Y[78#-%68H(Y$CIY2M^1"Z,B55NL)ER=D7/ZAGJ1Z0U%+9-UT7755
MMYP_RA&7Y*'J!U<$<^F-E5:PV =4O0[_++_QGO[H^KQ';Y1011A68X0?F[2#
MYI!VC3Q4S9-FH>XN2!O,^\D=!*CO;I0* _H/E^<I7TY!3"^5*K\(*>3W//*5
M$['H-.BI0 8F6;4,7+Y0<1*O&(:.N0>M(A0?T!VHEDYG%0\#4B3J.\1 1+ _
M-JV)YM":$:/U/2U-FT?<7E.PU2K:LI)T81GR]5NR_@BT,&X,+6 7@O9=Q*!;
M[U"E!9=V87*/LDA5EH3>:(.[#/RNFE2M).NJ#&2V >RDJ[E8FZ+[8U/+;6.H
MA4ZI;F2=&]R6C)6.^N8G8NY)5'-4",X05J7F V6+P_J,E\81I<1H![J)2XV%
MT.6'*:CMDK1V[K*C?;[^-RGB?%3T,FD6O5R!-HO[O]JB>$T7Y5)5L%*8B\I@
M_H+2C8.8@I_+HF.RLS/X2Z0@&T,*<-"<O%Q[T!3-JC0=5'MAZY+PVR3.,:>F
MVD$Q2-"M%J@L^=WFP^;_WKS-=XL2GI5\A#7E/UC]4^T$RV:L5\KM8%7$E^0[
M?'A+J](XCX_^//!>4Y#4=FUSOF7;G!\Q]O'B6S?0:1]LKH/.AK XKC"3]\H=
M8%*RVW=[%ZTZ XH<V?>WK@F]-./^-;IS#2%Q?#\HD^][6U.@D=:.?-<7:-<7
M:-<7: >!_:- 8&\'+ON.9KXGS>PZ >V(9=?R9T<ONY8_&UB?K6CYL^OPL^OP
MTTQAOSM-?H339%,=?G:W[6[;W;:[[?'=UHS>9-\]Q+3Q/6IH3[/!V7OW_.;2
MW=*F9G=-O4<)_AW,B"0@S*^\ !7EX_"!U<5_JB3YS]_TU?9UPU*GN9'[XS\7
MN7\^BH,E_&^23<-?_A]02P,$%     @ =*5%4_* /E41&   H)X  !$   !S
M:WEE+3(P,C$Q,# U+FAT;>U=:W?:RM7^WE\Q+WW;)ET6Z H23MSE8[ /.9&(
M;1P7OGB-I!$(ZT(E8<"_OGN/! :#+TF3&'R<M9( <]NSK\^>&8T^_&L:!N2&
M):D?1Q]+4EDLD7\=?/@_0?CW;V>?22-VQB&+,G*4,)HQETS\;$ N799>$R^)
M0W(9)]?^#14$WN8H'LT2OS_(B"S*TKW"I*ZKE*HB<P5#M6N":CM4L)DL"[K,
MQ*KA2K)7$_?Z=;VF,)W95<%P/$-0JSH3J*[+ G,4A<J&Y##1V7/KLLAT0Y2J
M3+)U%?Y20_,,@]J&[&E>U;!QV$$&LX,91FG=GWXL#;)L5*]4)I-)>6HG03E.
M^A59E)2*'P5^Q'#*I:(Z?+]^J(&H5+#8IBDK+7K/-M>^Z[F2)31*O3@):0;,
MAGYD41!E09*+3E8ZF"B\N6081F6*TU@:24B9LU(9OI?[\<VC@TF:(.J"(LW[
MF:;^I@%A=E+EW^;G<V? 0BKX49K1R%G,<[K&EQ5"L711%5C@/\+"^UV[[*XV
MKSF?%10@LW+*ZP&-^A]++!(NSDL@8$;=@P\ARRC!I@+[S]B_^5@ZBJ,,U%;H
MS$;0OY-_^UC*V#2K<&96#O[RE[]\R/PL8 ?I]8P).( DBMJ'2O[CATK>M1V[
MLX,/KG]#TFP6L(\EUT]' 9W5HSAB0( _K6-%EN0??==E$?\(Y1;83N([^?C3
M[(QY'TN^;=3L6LW5JDRV54EC>E5CDLQ<M^JJDJM4KQI(BFC(AC#_4"*Y(*'U
M-*M[_A1,R*,!:E]$0Z2)^?5#L%,7;?4XH/T2\5VH[2I?9W8COODLG]UT%7/L
M#ILWO1-CV!ZV)KU.7S,;3;G7.?;;C=-I=S@8M#M?PW8G&'2'U[/>\&MH#0/_
MLV(%W=MX9IY<J.W.X=0*+Z!N7S0O6VJW<RWUAM=:][*EF6$7/G>U;J"+G^7>
MK'OI5,U&7S(;IXH96J%YV12MQH5D-;#_LX$U[(JFW-7,RU.M?6G>N"?'OGUR
M4;4ZIU/SI#<PA]; //GD6R?-B7724GN="]4,3='JM";MDZ;<O;PHVGR%L;2H
MUXFA[^:D%S9GIMR<=,.6V.T<BC"OP.KT9]W;4\D<'@+-O4'OJS[YW&EFYKDX
MA?^!#Q?25=6UF68[NB!YKB*H2DT1;*UJ"**BZ)JN&4S7:J6#X\//Y\T/E14!
M_WAYWXFU&8$^SHY K@D-6I'+IG^PV9MXGQ+O=$V\:DT1'5F%D"/K&HC7%@6J
MNK:@>6[5TU374$6Y="""^].DJJ9):S*NK-IWPCR6,/!?Z0:WA'ZPGG(7"EI
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M%EV<1D[X237X2G/8"TKND?PQ)^ &9O8DH.G\P9OMW7XY&C#GFN #6W0T2F)
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MT,++WU]#41VX<4=Q)*3Y%F^NCTZ &K;ST+?#S^XEK!_S]#[/'!\VM@=9[<9
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M_]!QO;M.Q>:\77#*V<-WTX&6UDH*@1CI<B*=M\0!YT1SH,H$QF-._[4YT+D
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MO>?38?'%\" HS \"Q1/UG!,2_8'Y33I+]:>B\K"FX(5GF2=.6NC*+$ZL#IQ
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MQ0N'>[=O= _=#V</]_X'4$L! A0#%     @ =*5%4W;&RZ@D"@  @R$  !X
M             ( !     &$R,3$P,#%?<VMY96-F;V%N;F]U;F-E;65N+FAT
M;5!+ 0(4 Q0    ( '2E15/^O R6="\  )=/ 0 >              "  6 *
M  !A,C$Q,# T7W-K>65X:')X=7-X97AE8W5T:2YH=&U02P$"% ,4    " !T
MI453\H ^51$8  "@G@  $0              @ $0.@  <VMY92TR,#(Q,3 P
M-2YH=&U02P$"% ,4    " !TI453<?2=''$"  "!!P  $0
M@ %04@  <VMY92TR,#(Q,3 P-2YX<V102P$"% ,4    " !TI453BOAA4XH)
M  ! 5@  %0              @ 'P5   <VMY92TR,#(Q,3 P-5]L86(N>&UL
M4$L! A0#%     @ =*5%4_\+IVI"!@  !BT  !4              ( !K5X
L '-K>64M,C R,3$P,#5?<')E+GAM;%!+!08     !@ & )P!   B90     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
